Question 1

What is Nayzilam?

Accepted Answer

Nayzilam is a central nervous system depressant that belongs to a class of medications known as benzodiazepines. It works by slowing activity in the brain to help manage episodes of increased seizure activity. This medication is intended for short-term use when these episodes occur.

Question 2

What is Nayzilam used for?

Accepted Answer

Nayzilam is used to treat seizure clusters.

Question 3

How does Nayzilam work?

Accepted Answer

Mechanism of Action

Nayzilam belongs to a class of drugs called benzodiazepines. While the exact way it works is not fully understood, it is believed to help stop seizures by increasing the activity of certain natural chemicals in the brain.

The medication works by:

Enhancing GABA: It boosts the effects of gamma-aminobutyric acid (GABA), a chemical messenger that sends calming signals throughout the central nervous system.

Reducing Brain Activity: By increasing GABA activity, the drug helps slow down the intense electrical signals in the brain that lead to seizure clusters.

Because Nayzilam is a nasal spray, it is absorbed through the tissues in the nose. This allows the medicine to enter the bloodstream and reach the brain quickly during an emergency situation.

Question 4

What are the active ingredients in Nayzilam?

Accepted Answer

The active ingredient in Nayzilam is midazolam .

Question 5

What are the side effects of Nayzilam?

Accepted Answer

Common side effects of Nayzilam may include:

drowsiness

sedation

headache

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Nayzilam?

Accepted Answer

Nayzilam belongs to the benzodiazepine drug class.

Question 7

What is the dosage of Nayzilam and how do I take it?

Accepted Answer

How to Use

Nayzilam is for use in the nose only. It is intended for the short-term treatment of seizure clusters and should only be used when an episode of increased seizure activity occurs. A caregiver usually administers the medication while the person is having a seizure or immediately after one has started.

Each nasal spray unit is for one-time use only and contains a single dose. Do not test or prime the device before use, as this will waste the medication. To administer the dose:

Hold the device with your thumb on the bottom of the plunger and your first two fingers on either side of the nozzle.

Gently insert the tip of the nozzle into one nostril until your fingers are against the bottom of the nose.

Press the plunger firmly to release the medication.

The person receiving the medication does not need to breathe in deeply or sniff for the dose to be effective.

Dosing Frequency

A single dose is typically administered into one nostril. If the seizure does not stop or if seizures return, a second dose may be given in the other nostril if specifically instructed by a healthcare provider. There are limits on how many doses can be used for a single episode and how many seizure episodes can be treated over a specific period of time. Follow your healthcare provider's instructions exactly regarding when a second dose is appropriate.

Missed Dose

Because Nayzilam is used only as needed during a seizure emergency, it does not have a regular daily dosing schedule.

Question 8

Is Nayzilam safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited information regarding the use of Nayzilam in pregnant individuals. However, midazolam belongs to a class of drugs called benzodiazepines, which may cause harm to a developing fetus. If used during the later stages of pregnancy, there is a risk that the newborn may experience breathing problems, feeding difficulties, or excessive sleepiness.

Regular use of benzodiazepines during pregnancy can also lead to physical dependence in the infant, resulting in withdrawal symptoms after birth. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the risks of using this medication and whether there is a need to enroll in a pregnancy registry to monitor outcomes.

Breastfeeding

Midazolam passes into breast milk in small amounts. Because it can cause sedation, infants exposed to the drug through breast milk should be monitored for signs of central nervous system depression, including:

Increased sleepiness

Difficulty feeding

Poor weight gain

Breathing problems

Healthcare providers typically recommend weighing the benefits of breastfeeding against the potential risks to the infant before using this medication while nursing.

Question 9

What forms and strengths does Nayzilam come in?

Accepted Answer

Nayzilam is available as a nasal spray. It is supplied in single-use, disposable spray devices. Each device is designed to deliver the medication into a nostril.

The devices are individually packaged in blister packs to ensure they remain ready for use during a seizure emergency.

Question 10

What is the FDA approval status of Nayzilam?

Accepted Answer

FDA Approval and Indications

Nayzilam (midazolam) is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity, also known as seizure clusters or acute repetitive seizures. It is intended for patients with epilepsy who are 12 years of age or older and whose seizure patterns are distinct from their usual seizure activity.

Boxed Warning

The FDA requires a boxed warning for Nayzilam and all other benzodiazepines due to several significant safety risks:

Risks from Concomitant Use with Opioids: Using benzodiazepines alongside opioid medications can result in profound sedation, respiratory depression, coma, and death.

Abuse, Misuse, and Addiction: The use of benzodiazepines, even as prescribed, exposes users to the risks of abuse, misuse, and addiction, which can lead to overdose or death.

Physical Dependence and Withdrawal Reactions: Long-term use can lead to physical dependence. Stopping the medication suddenly or reducing the dose too quickly can cause life-threatening withdrawal symptoms.

Regulatory Classification

Nayzilam is classified as a Schedule IV controlled substance under the Controlled Substances Act. This classification is due to its potential for abuse, misuse, and the risk of developing physical or psychological dependence.

Safety Communications

In recent years, the FDA has updated the labeling requirements for the entire benzodiazepine class. These updates were mandated to provide more comprehensive information regarding the risks of addiction and the dangers of combining these drugs with other central nervous system depressants.

Question 11

What should I know about Nayzilam and cost?

Accepted Answer

Insurance and Pharmacy Factors

The amount you pay for Nayzilam is largely determined by your health insurance plan. Insurance companies often place brand-name drugs like Nayzilam into different cost tiers, which affects your copayment or coinsurance responsibility.

Pharmacy prices can also vary. It is often helpful to compare prices at different local pharmacies or through mail-order options provided by your insurance company.

Brand-Name Status

Nayzilam is a brand-name version of midazolam nasal spray. Generic medications are typically less expensive than brand-name ones; however, generic versions of this specific nasal spray formulation may not be available. You should consult with your healthcare provider or pharmacist to discuss the most cost-effective options for your treatment.

Nayzilam

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?